Literature DB >> 21396835

Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells.

Ming-Wei Lai1, Tse-Ching Chen, See-Tong Pang, Chau-Ting Yeh.   

Abstract

OBJECTIVE: The aim of this study was to understand the role of cyclin-dependent kinase-associated protein phosphatase (KAP) in renal cancer cell growth.
MATERIALS AND METHODS: Renal cell carcinoma (RCC) tissues from 58 patients receiving surgical resection were included for immunohistochemistry analysis. Additionally, human embryonic kidney (HEK293) cells overexpressing KAP were established for tumorigenicity experiments.
RESULTS: Clinicopathologic analysis indicated that poorly differentiated RCCs with a higher histological grade (grade 3/4) were associated with a higher proportion of KAP-positive cells (P < 0.001) as well as cytoplasmic expression of KAP (P < 0.05). HEK293 cells overexpressing KAP had a higher growth rate, greater resistance to TNF-α mediated increment of caspase 3 activity, a shorter cell cycle time, and greater ability of cell invasion. Tumorigenicity experiments showed that KAP-overexpressing cells generated significantly larger xenograft tumors in nude mice compared with mock controls (P = 0.032).
CONCLUSIONS: KAP expression was associated with poorly differentiated RCCs and overexpression of KAP in renal cells enhanced cell proliferation, resistance to apoptosis, invasive ability, and xenograft tumor formation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396835     DOI: 10.1016/j.urolonc.2010.09.010

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  15 in total

1.  CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.

Authors:  Li-Ping Zhang; Wen-Juan Li; Yuan-Fang Zhu; Shu-Ying Huang; Shan-Yu Fang; Li Shen; Yan-Ling Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 2.  Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years.

Authors:  Ayanda M Magwenyane; Samuel C Ugbaja; Daniel G Amoako; Anou M Somboro; Rene B Khan; Hezekiel M Kumalo
Journal:  Comput Math Methods Med       Date:  2022-05-31       Impact factor: 2.809

3.  CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.

Authors:  Hanxu Yu; Jun Yao; Mingyu Du; Jinjun Ye; Xia He; Li Yin
Journal:  Oncol Lett       Date:  2019-11-11       Impact factor: 2.967

4.  Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth.

Authors:  Wey-Ran Lin; Ming-Wei Lai; Chau-Ting Yeh
Journal:  Oncol Rep       Date:  2012-12-24       Impact factor: 3.906

5.  Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.

Authors:  Xiao Zang; Min Chen; Yunyun Zhou; Guanghua Xiao; Yang Xie; Xinlei Wang
Journal:  Cancer Inform       Date:  2015-05-24

6.  CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.

Authors:  Eira Valeria Barrón; Edgar Roman-Bassaure; Ana Laura Sánchez-Sandoval; Ana María Espinosa; Mariano Guardado-Estrada; Ingrid Medina; Eligia Juárez; Ana Alfaro; Miriam Bermúdez; Rubén Zamora; Carlos García-Ruiz; Juan Carlos Gomora; Susana Kofman; E Martha Pérez-Armendariz; Jaime Berumen
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

7.  A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.

Authors:  Qinghuang Chen; Ke Chen; Guijie Guo; Fang Li; Chao Chen; Song Wang; Grzegorz Nalepa; Shile Huang; Ji-Long Chen
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

8.  Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.

Authors:  Zofia Wotschofsky; Linda Gummlich; Julia Liep; Carsten Stephan; Ergin Kilic; Klaus Jung; Jean-Noel Billaud; Hellmuth-Alexander Meyer
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

9.  The tumor suppressor CDKN3 controls mitosis.

Authors:  Grzegorz Nalepa; Jill Barnholtz-Sloan; Rikki Enzor; Dilip Dey; Ying He; Jeff R Gehlhausen; Amalia S Lehmann; Su-Jung Park; Yanzhu Yang; Xianlin Yang; Shi Chen; Xiaowei Guan; Yanwen Chen; Jamie Renbarger; Feng-Chun Yang; Luis F Parada; Wade Clapp
Journal:  J Cell Biol       Date:  2013-06-17       Impact factor: 10.539

10.  Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.

Authors:  Miao Deng; Jianguang Wang; Yanbin Chen; Like Zhang; Gangqiang Xie; Qipeng Liu; Ting Zhang; Pengfei Yuan; Dechun Liu
Journal:  Mol Med Rep       Date:  2016-06-14       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.